Home › Esophageal Adenocarcinoma › North Carolina › Durham
Pag-aaral pangklinika para sa Esophageal Adenocarcinoma sa Durham, NC
Isang pag-aaral para sa Esophageal Adenocarcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Nagre-recruitPhase 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi ang layo
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Nagre-recruitPhase 2/3
- University of North Carolina Medical Center, Chapel Hill · 10 mi ang layo
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
Nagre-recruitPhase 2
- Duke University Medical Center, Durham
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Nagre-recruitPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Nagre-recruit
- University of North Carolina School of Medicine, Chapel Hill · 10 mi ang layo
Obeticholic Acid for Prevention in Barrett's Esophagus
Nagre-recruitPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Nagre-recruit
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Research Site, Durham
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Nagre-recruitPhase 2
- Durham VA Medical Center, Durham, NC, Durham
Pag-aaral para sa Esophageal Adenocarcinoma sa ibang lungsod
- New York City, NY18 pag-aaral
- Boston, MA13 pag-aaral
- Houston, TX12 pag-aaral
- Nashville, TN11 pag-aaral
- Arlington, VA11 pag-aaral
- Jacksonville, FL9 pag-aaral
- St. Louis, MO9 pag-aaral
- Rochester, MN9 pag-aaral
- Baldwin Park, CA9 pag-aaral
- Queens, NY9 pag-aaral
- Los Angeles, CA9 pag-aaral
- Dallas, TX8 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso64 pag-aaral
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Kanser sa Baga32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.